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dysfunctionAbstract Background: Postoperative cognitive dysfunction (POCD) in elderly patients is a com-
mon complaint after prolonged surgeries. In the present study, we aimed to investigate the effect
of intraoperative infusion of Dexmedetomidine on POCD.
Methods: 50 patients aged more than 60 years old undergoing elective abdominal surgery expected
to last more than 2 hours were randomized into 2 groups of 25 patients each: those receiving Dex-
medetomidine at a dose of 0.4 lg/kg/h, group (A) and those receiving 0.9% normal saline as pla-
cebo group (B). All patients underwent neuropsychometric tests (Montreal cognitive assessment
and Stroop color word interference tests) the day before the surgery and 24 h after the surgery,
and one week postoperatively.
Results: The use of Dexmedetomidine as an adjuvant during Sevoﬂurane anesthesia did not have
signiﬁcant effect on protection against POCD in one day and one week postoperatively. The
anesthetic and analgesic sparing effect of Dexmedetomidine was signiﬁcantly proved by lower Sevo-
ﬂurane need and signiﬁcant lesser amount of total 24 hours postoperative Fentanyl requirements,
but with signiﬁcant prolonged extubation and orientation times in Dexmedetomidine group than
placebo group.
Conclusions: The ﬁndings of this pilot study suggest that intraoperative use of Dexmedetomidine as
an adjuvant in major surgery in elderly patients was not associated with signiﬁcant protection
against POCD.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.D license.1. Introduction
Postoperative cognitive dysfunction (POCD) is a common and
well known complication after prolonged surgery. Especially
the elderly patients are at risk of cognitive dysfunction. But
due to the subtle nature of POCD, this complication might
be recognized only by the patient’s relatives. Thus, neuropsy-
chological testing is necessary for its detection [1]. Early
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ways. Delayed physical and emotional rehabilitation may
delay hospital discharge and return to work. Also, it can inter-
fere with accelerated care programs, which encourage a shorter
hospital stay and early independence. These problems may be
wrongly attributed to drugs or complications of surgery and
anesthesia [2].
Some neuro-pathophysiological studies have suggested that
post-operative cognitive disorder (POCD) might even share
some mechanisms with Alzheimer’s disease through deposition
of plasma b amyloid and Tau phosphorylation [3,4].
Dexmedetomidine is a potent and highly selective alpha 2
adrenergic receptor agonist. It provides sedation with modest
analgesic and possible anti delirium effects, but with minimal
respiratory depression. In addition, the use of alpha 2 agonists
has been associated with lower cardiovascular complications in
high-risk non-cardiac surgery [5,6]. Taken together, Dexmede-
tomidine could provide speciﬁc advantages over commonly
used analgesic and sedative agents for prolonged surgeries.
Besides, Dexmedetomidine’s well-established sedative
effects on increasing of both in vitro and in vivo evidence indi-
cate that Dexmedetomidine also has a cell-protective effect on
nervous tissue under ischemic conditions [7]. Moreover, there
is recent evidence suggesting that this effect is mediated by
the binding to imidazoline 1-recepors, which are known to
be important regulators for cell survival and mediators of neu-
roprotective effects of many drugs [7–9].
In this randomized double blind pilot study, we aimed to
examine whether the intraoperative use of Dexmedetomidine
was associated with a lower incidence of neurocognitive dys-
function in elderly patients undergoing elective prolonged
abdominal surgery when compared to Placebo.
We also assume that Dexmedetomidine by its analgesic and
sedative effect can be adjuvant to inhaled anesthetics and can
help in lowering the concentration of inhaled anesthetics and
analgesic consumption that added a role in protection from
POCD.
2. Methods
This was a pilot, randomized, double-blinded, controlled clin-
ical trial. It was conducted in a tertiary referral hospital (King
Faisal Specialist Hospital and Research Center, Jeddah, Saudi
Arabia). Ethics approval for this study was provided by the
institutional Ethics Committee of the hospital on 18/04/2010.
The study was registered with the Australian New Zealand
Clinical Trials Registry (ACTRN12613000378729).
Written informed consent was obtained from all patients.
50 patients men and women 25 patients per group, aged
60 years or older, American Society of Anesthesiologists
(ASA) physical status classes I to III, scheduled for elective
abdominal surgery (expected to be longer than 2 h), hospital
stay >48 h, and educable, were included in this study.
All participants were given a written description of their
involvement in the research, the neurocognitive test to be
made, their rights and how their rights and interests will be
protected, particularly in respect of conﬁdentiality, privacy
and safety. And all participants are made aware of their ability
to withdraw consent and discontinue participation at any time
exclusion criteria were patients with high vagal tone (heart rate
<60), any arrhythmic disorders, severe ventricular dysfunc-tion (EF <35%), hypovolemic patients, patients with any psy-
chological disorders, preexisting cognitive impairment, alcohol
or drug abuse, patients with preexisting CNS deﬁcit, or any
neurological symptomatic disorder conﬁrmed by MRI,
patients who showed inability or unwillingness to abide by
the protocol, inability to follow procedures, or poor compre-
hension of the language used in the study, and patients with
severe visual or auditory handicap.
The patients were randomly allocated to one of two groups,
Dexmedetomidine (A) group and a control (B) group, using a
computer-generated sequence of random numbers and a sealed
envelope technique. Study drugs were prepared by a pharma-
cist who did not participate in either the intraoperative man-
agement or the postoperative care. According to the
randomization table, drugs were prepared in unlabeled 50 ml
syringes. The unlabeled syringes were ﬁlled with normal saline
or with Dexmedetomidine. Both the patients and the investiga-
tors were blinded to the study drug.
Our primary endpoint was the proportion of patients in
each treatment group who was diagnosed to have POCD,
while the secondary end points were included the estimation
of intraoperative Sevoﬂurane consumption, Fentanyl con-
sumption, depth of anesthesia, and emergence time. Partici-
pants were recruited from the outpatient clinic for anesthesia
for preoperative evaluation. The preoperative interview
included a medical and surgical history, current medications,
alcohol consumption and substance use history, any neurolog-
ical or psychological disorders, and ASA classiﬁcation. Echo
cardiography in addition to routine laboratory investigation
and Electrocardiography was ordered.
2.1. Neuropsychometric evaluation
The baseline cognitive functions were conducted by a trained
interviewer who was blinded to patient’s allocation, for each
patient, a day before surgery and repeated 24 h postoperatively
and one week later. The tests used in this study were the
following:
(A) Stroop color word interference test, which estimates the
directed attention, mental speed and mental control
using a booklet consists of 3 basic parts: (1) word page;
the s patient reads words of color names (e.g., red, blue)
printed in black ink. (2) Color page: the patient identiﬁes
colors (e.g., rectangles printed in red or blue). (3) Color-
word page; the patient should name the color in which a
word is written, while ignoring the printed word. Thus,
incongruence between the word’s color and identity
(e.g., the word ‘‘red’’ presented in green). Lower score
indicates higher performance [10,11].
(B) Montreal cognitive assessment test, which is a one page,
30 point test done in approximately 10 min for assess-
ment of attention, memory, abstraction, delayed recall
and orientation, with total score of 30, the short-term
memory recall task (5 points) contains 2 learning trials
of 5 nouns and delayed recall after approximately
5 min. Visuospatial abilities are assessed by a three-
dimensional cube copy (1 point) and a clock-drawing
task (3 points). Many ways of executive functions are
evaluated using an alternation task adapted from the
trail-making B task (1 point), a phonemic ﬂuency task
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points). Attention, concentration and working memory
are evaluated using a sustained attention task (target
detection using tapping; 1 point), digits forward and
backward (1 point each) and a serial subtraction task
(3 points). And language is evaluated using a three-item
confrontation naming task with low-familiarity animals
(lion, camel, rhinoceros; 3 points), the aforementioned
ﬂuency task, and repetition of two syntactically complex
sentences (2 points). Finally, orientation to time and
place is evaluated (6 points). To keep the learning effects
to a minimum, parallel equivalent forms have been used
to decrease learning effects [12,13].
2.2. Intraoperative
All patients were monitored by ﬁve-lead electrocardiograph, a
peripheral pulse oximeter, a noninvasive blood pressure device,
a capnograph, airway gas analysis, neuoromuscular monitor-
ing, and nasal temperature sensor. Hypothermia was pre-
vented with a forced air warming blanket, and depth of
anesthesia was monitored using a built in Entropy (GE
Entropy, GE Healthcare Finland Oy, Helsinki, Finland).
Ten minutes before induction, a blinded study drug bolus
infusion was started at 1 lg/kg/h for ten minutes intravenously
and then induction was done by a blinded investigator using
intravenous injection of Propofol 1–2 mg kg1, Fentanyl 1–
2 lg kg1, and Rocuronium mg kg1 followed by intubation
and controlled mechanical ventilation to maintain end-tidal
carbon dioxide at 35 ± 5 mmHg. Anesthesia was maintained
using Sevoﬂurane with oxygen/air inspired gas mixture in a
low ﬂow breathing system (FiO2 = 0.5) Sevoﬂurane starting
with (1–1.5%) and the concentration was titrated 0.1% every
5 min guided by its end tidal concentration to maintain depth
of anesthesia using Entropy. Its value should be maintained as
close to 45–55 as clinically practical.
Infusion of the blinded drug either Dexmedetomidine
(Precedex, Abbott Laboratories, Abbott Park, IL) or 0.9%
normal saline at a rate of 0.4 lg kg h by a syringe pump main-
tained until end of surgery. Fentanyl was infused at a rate of
0.5 lg/kg/h and boluses of Rocuronium 0.2 mg/kg i.v accord-
ing to the neuromuscular monitoring.
Fentanyl infusion and the study drug infusion were discon-
tinued concomitantly with starting closure of surgical incision.
At the end of the surgery, Sevoﬂurane inhalation was discon-
tinued and local anesthesia inﬁltration of 0.25% plain bupiva-
caine was injected by the surgeon around the incision site,
concomitant with i.v injection of 10 mg/kg paracetamol and
Lornixicam 8–16 mg i.v as a subsequent analgesia. Tracheal
extubation after the neuromuscular blockade was reversed
with intravenous Glycopyrollate 0.1 mg/kg followed by neo-
stigmine 0.05 mg/kg.
The following collected data were recorded intraopera-
tively: heart rate, mean arterial blood pressure, ﬂuids intake,
blood loss, core temperature, end tidal Sevoﬂurane, Entropy
values every 5 min in ﬁrst 30 min and then every 15 min, Extu-
bation time, Fentanyl consumption, surgery and anesthesia
times, eye opening time, and orientation time.
The patient was transferred to the Post Anaesthesia Care
Unit (PACU) and a trained nurse was assigned to start PCApump (Graseby 3300, Graseby Medical Ltd, Watford, UK)
fentanyl, with 50 microgram per ml, and lock out of 6 min.
And give 25 lg Fentanyl as boluses as rescue analgesic if
numerical rating scale (NRS) > 3. The patients were moni-
tored for hemodynamics, and pain assessment by NRS was
done, by asking the patient to verbally rate his level of pain
intensity on a numerical scale from 0 to 10 with, (0) represent-
ing no pain, and (10) is the other extreme (worst possible pain).
Sedation level was assessed by Ramsay sedation score
(patients graded as 1: anxious, 2: oriented and tranquil, 3:
respond to commands, 4: brisk response to stimulus, 5: slug-
gish response to stimulus, 6: no response to stimulus). Patients
were considered ready for discharge from PACU when they
attained Alderet score reaches 9–10 (Table 1), free of pain,
nausea or vomiting. 24 h postoperatively, we recorded NRS
on rest and movement, analgesic consumption, and neuropsy-
chological tests, then repeat the neurocognitive tests after one
week provided that patient will come to follow up in clinic or
stayed at hospital.
We chose to use 1 SD rule to deﬁne cognitive dysfunction in
each test because it has recently been shown to be associated
with fewer false positives results (14). If the two tests were
not completed at one time point, assessment for deﬁcit was
omitted, as POCD in each patient was deﬁned as two or more
abnormal test results.
2.3. The statistical analysis
We accepted a type I error of 0.05 and a type II error of 0.80 for
detecting a true difference. A 0.5 or greater difference in inde-
pendent variables was considered clinically signiﬁcant. An esti-
mate of standard deviation in independent variables was 1. As a
result, we calculated that minimum 23 patients were needed in
each group in order to obtain 5% type 1 error and an 80%
power of detecting a difference of 0.5 or more. For each group,
25 patients were included to compensate for possible drop-outs.
The power calculation was performed with nQuery Advisorw
Version 7.0 (Statistical Solutions, Saugus, MA, USA).
Data were statistically described in terms of mean standard
deviation (SD), and range, or frequencies (number of cases)
and percentages when appropriate. Comparison of numerical
variables between the study groups was done using Student t
test for independent samples in comparing 2 groups when nor-
mally distributed and Mann Whitney U test for independent
samples when not normally distributed. Within the group,
comparison of quantitative data was done using Paired t test
for normal data and Wilcoxon Signed Rank test for non-nor-
mal data. For comparing categorical data, Chi square (2) test
was performed. Exact test was used instead when the expected
frequency is less than 5. Within group comparison was done
suing McNemar test. p values less than 0.05 was considered
statistically signiﬁcant. All statistical calculations were done
using computer program SPSS (Statistical Package for the
Social Science; SPSS Inc., Chicago, IL, USA) version 15 for
Microsoft Windows.3. Results
Fifty-eight patients scheduled for elective abdominal surgery
expected to last for more than 2 h, participated in this study.
Table 1 Aldert score: criteria for patient discharge from post anesthesia care unit (patient can be discharged from PACU when Aldert
score is 9 or 10).
0 1 2
Activity Unable to sit Unable to sit without assistance Able to sit or stand without assistance
Respiration Apnea Depressed from preoperative rate Same or more than preoperative rate
Circulation >50% lower than base SBP 20–50% lower <20% lower
Color Cyanosis Pale Normal
Consciousness Unresponsive to verbal stimuli Respond to verbal stimuli Fully awake
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ria. Two patients, 1 from each group, were excluded after
enrollment because of study protocol violations. Of the
remaining 50 patients, 25 patients were randomized into Dex-
medetomidine group (group A) and a control group (group B).
The two groups were not statistically different for the degree
of education, ASA status, duration of anesthesia, the duration
of the surgery and the demographic data (Table 2), (except for
higher proportion of males in both groups (p= 0.05).
When each individual was analyzed by 1 SD rule, the inci-
dence of POCD at 1 day by Montreal cognitive assessment test
in either group was 20% (5 patients) nonstatistically signiﬁcant
(P= 0.99), while at one week POCD was diagnosed in 24% (6
patients) in group A and 20% (5 patients) in group B, and this
was nonsigniﬁcant (P= 0.73).
Using Stroop color word interference test in group B, there
was statistically higher incidence of POCD at 1 day than in
group A 80% (20 patients) vs. 16% (4 patients), respectively
(P= 0.00). Moreover, at one week, there was a decrement in
incidence of POCD in both groups, but still statisticallyTable 2 Demographic data, types of operations, and contin-
uous variables are presented as mean ± SD, and categorical
variables are presented as frequency (%). M:F, male:Female;
N, absolute number.
Group A Group B
Age (y) 63.92 ± 4.99 67.80 ± 5.37
Anesthesia duration (h) 4.81 ± 2.30 4.44 ± 2.1
M:F 20:5 25:0
ASA 1.2.3 2:4:19 3:6:16
Education level (secondary) N (%) 19 (%) 20 (%)
(college) N (%) 6 (24%) 5 (20%)
Radical prostatectomy, N 0 10
Resection anastomosis, N 3 0
Abdominoperineal, N 0 5
Adrenelectomy, N 0 5
Anterior resection, N 4 0
Colectomy, N 7 5
Laparotomy, N 3 0
Radical cystectomy, N 5 0
Hystrectomy, N 3 0
Table 3 Proportion of patients with post operative cognitive dysfu
considered signiﬁcant; P value less than 0.00 is considered highly sig
One day One day
Montreal test P value Stroop color test P
Group A (n) % (5/25) 20% 0.99 (4/25) 16% 0.
Group B (n) % (5/25) 20% (20/25) 80%signiﬁcantly higher in group B than group A 40% (10 patients)
vs. 8% (2 patients) respectively P= 0.00, Table 3.
Within each group comparing incidence of POCD between
1 day and 1 week revealed nonstatistically signiﬁcant differ-
ence in both neurocognitive tests except in Stroop color test
in group (B) where there was a statistically signiﬁcant differ-
ence between the two times periods .
The percentage changes of each group for each test are listed
in Table 4. There was statistically signiﬁcant difference in per-
centage change score between both groups at each time interval.
However, all tests in each group changed nonsigniﬁcantly with
time except in group B in Montreal cognitive assessment test.
Analysis of intraoperative data revealed that patients in
group (A) showed increased amount of Sevoﬂurane need at
induction associated with a decline in HR (60 beats/min), fol-
lowed by stable period and minimal ﬂuctuations around
60 beats/min, trend noted to be at lower values of HR rather
than the higher values of group B, which means more hemody-
namic stability. Also, group A patients achieved steadiness
with no great ﬂuctuations and no hypotensive episodes.
The percentage need of end tidal (ET Sevoﬂurane) for
group (A) was 1.8% at 60 min followed by period of stability
till the end of operation at 4 h, when we started to decrease the
amount of Sevoﬂurane for emergence. The Entropy values did
not increase proportionately in comparison with group B, and
the maximum percentage need of Sevoﬂurane was 2.2% and
associated with marked ﬂuctuations to achieve appropriate
depth of anesthesia (indicated by Entropy values).
Intraoperative use of vasopressor (Ephedrine) showed non-
signiﬁcant difference in between groups. In addition, intraop-
erative and PACU requirements of Fentanyl showed
nonstatistically signiﬁcant difference between both groups.
During emergence from anesthesia, patients in group A had
more prolonged time for extubation, eye opening, obey order
and orientation time than patients in group B.
At PACU, patients in placebo group (B) showed earlier ori-
entation and cooperation by Ramsay sedation score than
patients in study (see Fig. 1).
However, patients in group A remained statistically signif-
icant tranquilized for more prolonged period (90 min) than
patients in group B (P= 0.00), Fig. 2.nction by 1 SD rule in individual tests. P value less than 0.05 is
niﬁcant.
One week One week
value Montreal test P value Stroop color test P value
00 (6/25) 24% 0.73 (2/25) 8% 0.00
(5/25) 20% (10/25) 40%
Figure 1 Mean Entropy values between the study groups over the study period.
Table 4 Percentage change for each test. Data are presented as mean ± SD of percentage change from preoperative values, at 1 day
and 1 week in Montreal test average decrease in group A and average increase in group B, at 1 day and 1 week in Stroop color test
average decrease in group B and increase in group A.
Test Preoperative P value
between
groups
One day P value
between
groups
One week P value
between
groups
P value
across
time periods
Montreal group A 25.24 ± 3.05 0.00 2 ± 3.2 0.00 0.786 ± 0.4.497 0.000 0.16
Montreal group B 23.60 ± 3.74 2.90 ± 7.159 12.832 ± 18.839 0.00
Stroop color group A 24 ± 4.40 0.09 4.257 ± 8.768 0.02 6.974 ± 9.609 0.001 0.15
Stroop color, group B 20.20 ± 4.62 4.301 ± 16.288 2.734 ± 10.601 0.53
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between NRS during 24 h at rest in patients of group A with
score not exceeding 1.50, while NRS in group B still mild with
higher values not exceeding 2. Moreover, NRS during 24 h
period at movement were considered signiﬁcantly lower at
group (A) with values less than or equal to 3, in comparison
with group (B) with values less than or equal to 4 (see Fig. 3).
Those results correlate with the total 24 h postoperative
Fentanyl consumption, in group (A) patients required
290 ± 37.63 lg Fentanyl, compared to 562 ± 214.98 lgFigure 2 Mean Ramsy sedation score betweeFentanyl consumption in group (B) that indicates statistically
highly signiﬁcant (p= 0.00).4. Discussion
The results of our pilot 2-arm randomized trial demonstrates
nonstatistically signiﬁcant lower incidence of POCD, during
one day and one week postoperatively in patients who
received Dexmedetomidine. Besides, these patients had stablen the study groups over the study period.
Figure 3 The study ﬂow chart.
336 S. Mohamed, A.R. Shaabanhemodynamics, lower anesthetic and analgesic consumption,
although concomitant with delayed emergence and prolonged
recovery time in PACU.
Changes in cognitive status after surgery may present in the
form of delirium or POCD. Delirium is deﬁned as an observa-
tional changes that occur in consciousness, with perceptual dis-
turbance, disorganized thoughts and hyper or hypoactive
psychomotor activity, whereas in POCD patients exhibiting
declines from his own baseline level of performance in one
or more neuropsychologic domains [15,16].
POCD often goes unrecognized in the clinical setting
although its incidence of occurrence is 19–47% in noncardiac
surgery. It is a more persistent problem and is usually detected
with neuropsychologic tests [17–19].
In this study, we included patients with higher level of edu-
cation as according to the cognitive reserve hypothesis. Educa-
tion level affects susceptibility to POCD and that suggests that
a higher level of education seems to protect against decline
after cardiac surgery [20]. We also included patients above
60 years old as elderly patients undergoing major surgery are
more prone to have POCD as evident in a large well designed
study data [21]. We chose to analyze the test results using 1 SD
rule. A previous study on cognitive decline after CABG sur-
gery done by Van Dijk et al. used the 20% rule to deﬁne the
prevalence of POCD. Recently, that group reassessed their
data using the 1 SD rule and got the conclusion that the
reported incidence of POCD at 3 months decreased from
25% to 10.5% [14].Also, it had been recently shown that, in the absence of a
control group, the 1 SD rule shows less false positives than
the 20% rule. This explains the lower rates of POCD found
when the 1 SD rule is used to deﬁne POCD. For this reason,
we decided to use the incidence of POCD as deﬁned by the 1
SD rule for exploratory analysis using logistic regression [18].
Postoperative cognitive dysfunction after prolonged sur-
gery has been the subject of many investigations. Some of these
studies have shown some factors associated with POCD, but
none have been solely or consistently implicated [22,23]. Yuji
study concluded no relationship of Sevoﬂurane to POCD after
cardiac surgery in a study done on 109 patients; his study did
not prove that Sevoﬂurane had preconditioning effect on the
brain as on heart to improve the neurological outcome, as sug-
gested by studies done on animal’s models [24].
In our study, the use of Dexmedetomidine did not show a
protective effect on the development of POCD. The result
may be surprising, but if it is true, it contradicts the original
assumption that Dexmedetomidine has a neuroprotective
effect. And also to the study done by Maldonado et al., who
reported that postoperative sedation with Dexmedetomidine
was associated with signiﬁcantly lower rates of postoperative
delirium in cardiac surgery (3%) [25].
However, Norimasa and his colleagues studied the recovery
proﬁle of both sevoﬂurane and propofol when Dexmedetomi-
dine was added to both as a general anesthetic adjuvant in
patients undergoing lower abdominal surgery. They
revealed that the addition of Dexmedetomidine did not affect
Dexmedetomidine and cognitive dysfunctionominal 337postoperative cognitive functions [26]. Moreover, Suleman
study concluded Dexmedetomidine used as an adjuvant anes-
thetic agent in cardiac surgery has no neuroprotective effect
against cerebral ischemic injury, by serial measurements of
neurons – speciﬁc enolase and serum100B protein, but he rec-
ommended larger population than his study sample size
(twenty-four patients) [27].
In our study, the use of Dexmedetomidine was associated
with hemodynamic stability, lower end-tidal Sevoﬂurane
(around 1.8%) and a stable anesthetic depth detected by
Entropy (ﬁgure around 46) in Dexmedetomidine group
patients that is related to anesthetic sparing effect of Dexmede-
tomidine and similar to previous studies [28,29]. The extuba-
tion and orientation time were signiﬁcantly prolonged in
Dexmedetomidine group than placebo group patients, which
was attributed to the sedative effect of Dexmedetomidine. Bur-
cu study [30] revealed different concentrations of Dexmede-
tomidine infusion failed to facilitate faster emergence, but
shorter times than our study that was attributed to prolonged
time of infusion.
Postoperative analgesic requirements during 24 h was con-
sidered signiﬁcantly lower in Dexmedetomidine group
patients, associated with lower values of NRS at rest and
movements. The analgesic sparing effect of Dexmedetomidine
would have persisted for up to 24 h postoperatively and also
the thymoanaleptic properties of alpha 2 agonists that affect
the emotional component of postoperative pain had also a
role.
A limitation of our study is that we assessed short term
POCD at 1 day and 1 week, a small sample size, and that we
could not determine whether the etiology of POCD in postop-
erative day (1) is different from that at 1 week.
5. Conclusion
This pilot study of POCD in elderly patients after major sur-
gery has shown nonstatistically signiﬁcant difference in the
incidence of POCD in day 1 & ﬁrst week postoperatively
between Dexmedetomidine and placebo group. And we did
not prove that Dexmedetomidine infusion can be a helpful
adjuvant in general anesthesia to reduce risk of POCD. In spite
of its anesthetic–analgesic sparing effect, we recommend a lar-
ger population study in the future to prove its role in protec-
tion against POCD.
Trial Registery
This study was registered with the Australian New Zealand
Clinical Trials Registry (ACTRN12613000378729).
Conﬂict of Interest
None.
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